drugset / Trial / NCT03641079

Identification of Compound From Brinjal Peel Extract in the Treatment of Palmar Arsenical Keratosis and Bowen's Disease

NCT03641079 ↗

NaSingle-groupOpen-labelTreatment

Summary

Arsenicosis is a major health problem in Bangladesh. Long term exposure of arsenic causes keratosis of palm which reduce working capacity of patient. It also causes invasive skin lesions like Bowen's disease which has a risk to develop squamous cell carcinoma. Brinjal peel is well known for its antioxidant and anticancer properties. So this study will be conducted to identify the compound from brinjal peel extract and to see its outcome on keratosis and Bowen's disease.

Timeline

Start
2017-09-16
Primary completion
2018-12
Completion
2019-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Brinjal peel extract Unknown — Topical

Indications

No indication recorded.